Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: RXGOLF who wrote (11253)	8/16/1999 10:19:00 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Xoma has said LONG before it unblinded that they would be stingy with information. As far as I know this is the FIRST biological of this kind to come before the FDA and maybe the first or very close to the first BIOLOGICAL with sub-part E. status. As you know the 2 1/2 ditto you are talking about was NOT the first inhibitor of viral replication of protease origin. Has it ever occurred to you that kids don't have powerful lobby groups like grownups stricken by aids? There is no high profile lobby for kids stricken with Meningo. Xoma is a company with MEAGER funds trying its best to appease a daunting FDA in my opinion. I sincerely hope you are right in that I might be able to buy more shares on the cheap.